John Kotek

Sr. Director at Versartis Inc - Menlo Park, California, United States

John Kotek's Colleagues at Versartis Inc
Camille Shore

Sr. Director, Regulatory Affairs

Contact Camille Shore

John Kotek's Contact Details
HQ
Location
Plainsboro Township,New Jersey,United States
Company
Versartis Inc
John Kotek's Company Details

Versartis Inc

Menlo Park, California, United States • 1 Employees
Pharmaceuticals

Versartis, Inc. is an endocrine-focused biopharmaceutical company. The Company is engaged in developing a long-acting form of recombinant human growth hormone, somavaratan (VRS-317), for growth hormone deficiency (GHD), an orphan disease. The Company's first indication for somavaratan is pediatric GHD. The Company may develop somavaratan for additional growth disorders, such as idiopathic short stature (ISS), small for gestational age (SGA) and Turner Syndrome. Somavaratan is engineered using XTEN technology to extend the residence time in the bloodstream by reducing the clearance of recombinant human growth hormone (rhGH) from the body by the two primary mechanisms, kidney filtration and receptor mediated clearance.

Details about Versartis Inc
Frequently Asked Questions about John Kotek
John Kotek currently works for Versartis Inc.
John Kotek's role at Versartis Inc is Sr. Director.
John Kotek's email address is ***@aravive.com. To view John Kotek's full email address, please signup to ConnectPlex.
John Kotek works in the Pharmaceuticals industry.
John Kotek's colleagues at Versartis Inc are Camille Shore and others.
John Kotek's phone number is
See more information about John Kotek